Latest insight from Symbiosis IP
-
Article / Insight
IP Advance funding: What you need to know
In this insight we provide a brief overview of the IP Advance scheme which is intended to support SMEs looking to explore, or enhance, their IP portfolios.
-
Article / Insight
Will the new Government secure growth for university spinouts beyond the Golden Triangle?
Change may be on the horizon for the UK’s university spinout sector. We explore whether this will help to spread investment and opportunity more evenly for spinouts…
-
Article / Insight
Decoding intellectual property valuation: Why the ‘human touch’ is still important
A recent report by the WIPO and UK IPO highlighted AI’s potential as a lower cost alternative to custom IP valuations. Here, we discuss why understanding the true v…
-
Article / Insight
G1/22 and G2/22: Enlarged Board of Appeal decision on priority entitlement
-
Article / Insight
EPO extends its reach in Eastern Europe via a validation agreement with Georgia. Will this trend continue?
-
Article / Insight
European Patent Office abolishes the ‘10-day rule’
-
Article / Insight
A guide to the Unitary Patent system and Unified Patent Court in Europe
-
Article / Insight
UK IPO processivity 2022
Related
Meet our latest featured author
Mark Hoggins PhD CPA EPA
Symbiosis IP
Director & Patent Attorney
Mark specialises in chemistry-related patents, gaining considerable experience in protecting and maintaining the worldwide commercial interests of private corporate clients and publicly quoted multinational corporations.
-
Article / Insight
G1/22 and G2/22: Enlarged Board of Appeal decision on priority entitlement
This decision by the Enlarged Board of Appeal provides an important update on how priority claims will be assessed on European patent applications affecting applica…
-
Article / Insight
European Patent Office abolishes the ‘10-day rule’
In order to adapt to the digital age, the European Patent Office introduced a package of rule changes, including abolishing the ‘10-day rule’.